Description
BAY-1251152 is an inhibitor of PTEFb/CDK9. PTEFb contributes to the regulation of gene transcription and can be over-expressed in cancer cells, leading to the transcription of key tumor-promoting genes and proliferation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
BAY-1251152 is an inhibitor of PTEFb/CDK9. PTEFb contributes to the regulation of gene transcription and can be over-expressed in cancer cells, leading to the transcription of key tumor-promoting genes and proliferation.
| Cas No. | 1610358-56-9 |
|---|---|
| Purity | ≥98% |
| Formula | C19H18F2N4O2S |
| Formula Wt. | 404.44 |
| IUPAC Name | 5-Fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]-2-pyridinyl}-2-pyridinamine |
| Synonym | BAY 1251152, BAY1251152 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Luecking U., Scholz A., et al. Identification of potent and highly selective PTEFb inhibitor BAY 1251152 for the treatment of cancer: from p.o. to i.v. application via scaffold hops. Cancer Res. 77(13 Suppl):Abstract nr 984 (2017).
Synthetic peptide derived from HIV-1; viral fus...
mTOR activator.
Phytoalexin, indole found in cruciferous vegeta...
Selective and reversible JAK inhibitor.
Sartan
PKC activator, carcinogen.
Non-essential amino acid alcohol.
NSAID; COX-2 inhibitor.
Dipeptide; aminopeptidase (N/CD13) inhibitor.
MEK1/2 inhibitor.
Phenol found in Zingiber; 5-HT3 antagonist.
NSAID; COX-1/2 inhibitor.
Xanthine derivative; adenosine antagonist, PDE ...
ROS1, MET, Ron, Axl, TIE-2, VEGFR2 inhibitor.
β1-adrenergic antagonist.
Endogenous purine derivative of xanthine.
Isoflavonoid found in Glycyrrhiza; GABA-A posit...
Polypeptide; peptidoglycan inhibitor.
Endogenous calcitonin-family peptide, involved ...
β2-adrenergic agonist.